**Core Concept**
Filgrastim and sargramostim are both recombinant human growth factors used to stimulate the production of white blood cells in the bone marrow. Filgrastim is a granulocyte colony-stimulating factor (G-CSF), while sargramostim is a granulocyte-macrophage colony-stimulating factor (GM-CSF). These growth factors have distinct mechanisms of action and effects on the immune system.

**Why the Correct Answer is Right**
Sargramostim (GM-CSF) has a broader spectrum of action than filgrastim (G-CSF), stimulating the production of both granulocytes and macrophages in the bone marrow. This is because GM-CSF binds to its receptor on the surface of hematopoietic stem cells, which then differentiate into both granulocytes and macrophages. In contrast, G-CSF primarily stimulates the production of granulocytes. Sargramostim is often used in the treatment of certain types of cancer, such as acute myeloid leukemia, and in the stimulation of immune responses in patients with HIV/AIDS.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the distinct mechanism of action of sargramostim compared to filgrastim.
**Option B:** This option is incorrect because it is too vague and does not provide any specific information about the differences between sargramostim and filgrastim.
**Option C:** This option is incorrect because it is too broad and does not accurately describe the specific effects of sargramostim on the immune system.

**Clinical Pearl / High-Yield Fact**
It is essential to understand the differences between G-CSF and GM-CSF when selecting a growth factor for the treatment of neutropenia or other hematologic disorders. GM-CSF, such as sargramostim, may be preferred in certain situations due to its broader spectrum of action.

**Correct Answer: A.**